Argentina, Mexico to produce AstraZeneca COVID-19 vaccine

Argentina's President Alberto Fernandez gestures during the announcement that Argentina and Mexico will produce and distribute an experimental coronavirus vaccine, at the Olivos Presidential residence, in Buenos Aires, Argentina August 12, 2020. Juan Mabromata/Pool via REUTERS

BUENOS AIRES (Reuters) - Argentina and Mexico will produce the AstraZeneca COVID-19 vaccine for most of Latin America, Argentine President Alberto Fernandez said on Wednesday after a meeting with company executives involved in the project.

An agreement signed between British pharmaceutical company AstraZeneca and the biotechnology company mAbxience of the INSUD Group includes transfer of technology to initially produce 150 million doses of the vaccine to supply all of Latin America with the exception of Brazil, the Argentine government said.